These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34191189)

  • 1. Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and
    Fukushima K; Nagao M; Yamamoto A; Serizawa N; Ishizaki U; Suzuki A; Sakai A; Watanabe E; Momose M; Kuji I; Abe K
    Eur J Hybrid Imaging; 2019 Jun; 3(1):9. PubMed ID: 34191189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid CMR- and FDG-PET-Imaging Gives New Insights Into the Relationship of Myocardial Metabolic Activity and Fibrosis in Patients With Becker Muscular Dystrophy.
    Vehof V; Büther F; Florian A; Drakos S; Chamling B; Kies P; Stegger L; Yilmaz A
    Front Cardiovasc Med; 2022; 9():793972. PubMed ID: 35174232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury.
    Wang L; Yan C; Zhao S; Fang W
    Clin Nucl Med; 2012 Dec; 37(12):1163-9. PubMed ID: 23154474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular magnetic resonance imaging characteristics and influence factors of aortic insufficiency patients with myocardial fibrosis].
    Zheng YC; Lu MJ; Chen XY; Yang K; Yin G; Wang K; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):622-627. PubMed ID: 31434433
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of myocardial viability imaging by cardiac MRI and PET depending on left ventricular function.
    Hunold P; Jakob H; Erbel R; Barkhausen J; Heilmaier C
    World J Cardiol; 2018 Sep; 10(9):110-118. PubMed ID: 30344958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.
    Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV
    Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis.
    Mathijssen H; Tjoeng TWH; Keijsers RGM; Bakker ALM; Akdim F; van Es HW; van Beek FT; Veltkamp MV; Grutters JC; Post MC
    EJNMMI Res; 2021 Dec; 11(1):129. PubMed ID: 34928457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation.
    Muser D; Santangeli P; Liang JJ; Castro SA; Magnani S; Hayashi T; Garcia FC; Frankel DS; Dixit S; Zado ES; Lin D; Desjardins B; Callans DJ; Alavi A; Marchlinski FE
    JACC Clin Electrophysiol; 2018 Mar; 4(3):291-303. PubMed ID: 30089553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
    Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
    J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.
    Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Buecker A; Krombach GA; Buell U; Kühl HP
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):545-53. PubMed ID: 12589480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis.
    Yodogawa K; Fukushima Y; Tachi M; Fujimoto Y; Hagiwara K; Oka E; Hayashi H; Murata H; Yamamoto T; Iwasaki YK; Amano Y; Kumita SI; Shimizu W
    Int Heart J; 2022; 63(2):235-240. PubMed ID: 35354745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis.
    Cheung E; Ahmad S; Aitken M; Chan R; Iwanochko RM; Balter M; Metser U; Veit-Haibach P; Billia F; Moayedi Y; Ross HJ; Hanneman K
    Eur J Hybrid Imaging; 2021 Dec; 5(1):24. PubMed ID: 34913098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
    Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.